Pure alveolar rhabdomyosarcoma of the corpus uteri: Description of a case with increased serum level of CA-125

Gynecologic Oncology

Volumn 66, Issue 2, 1997, Pages 320-323

  Chiarle, Roberto ^a   Godio, Laura ^a   Fusi, Donatella ^b   Soldati, Tito ^b   Palestro, Giorgio ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b MOLINETTE HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CA 125 ANTIGEN; MUSCLE ANTIGEN; PROTEIN P53;

ABDOMINAL SCINTISCANNING; AGED; ANTIGEN EXPRESSION; ARTICLE; BLOOD LEVEL; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DISEASE COURSE; ECHOGRAPHY; FEMALE; HUMAN; HYSTERECTOMY; IMMUNOHISTOCHEMISTRY; PHYSICAL EXAMINATION; PRIORITY JOURNAL; RHABDOMYOSARCOMA; SALPINGOOOPHORECTOMY; UTERUS CANCER;

EID: 0031214485     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.1997.4742     Document Type: Article

References (19)

1. Kempson R L, Bari W. Uterine sarcomas: classification, diagnosis and prognosis. Hum Pathol. 1:1970;331-349.
2. Horn R C Jr, Enterline H T. Rhabdomyosarcoma: a clinicopathological study and classification of 39 cases. Cancer. 11:1958;181-199.
3. Hart W R, Craig J R. Rhabdomyosarcoma of the uterus. Am J Clin Pathol. 70:1978;217-223.
4. Copeland L J, Sneige N, Stringer C A, Gershenson D M, Saul P B, Kavanagh J J. Alveolar rhabdomyosarcoma of the female genitalia. Cancer. 56:1985;849-855.
5. Podczaski E, Kaminski P F, Zaino R J. CA 125 and CA 19-9 immunolocalization in normal hyperplastic, and carcinomatous endometrium. Cancer. 71:1993;2551-2556.
6. Koelma I A, Nap M, Rodenburg C J, Fleuren G J. The value of tumour marker CA 125 in surgical pathology. Histopathology. 11:1987;287-294.
7. Loy T S, Quesenberry J T, Sharp S C. Distribution of CA 125 in adenocarcinomas. An immunohistochemical study of 481 cases. Am J Clin Pathol. 98:1992;175-179.
8. Macdonald F, Downing R, Allum W H. Expression of CA 125 in pancreatic carcinoma and chronic pancreatitis. Br J Cancer. 58:1988;505-506.
9. Levine A J, Momand J, Finlay C A. The p53 tumour suppressor gene. Nature. 351:1991;453-455.
10. Kawai A, Noguchi M, Beppu Y, Yokoyama R, Mukai K, Hirohashi S, Inoue H, Fukuma H. Nuclear immunoreaction of p53 protein in soft tissue sarcomas: a possible prognostic factor. Cancer. 73:1994;2499-2505.
11. Kulka E W, Douglas G W. Rhabdomyosarcoma of the corpus uteri: report of a case, associated with adenocarcinoma of the cervix, with review of the literature. Cancer. 5:1952;727-736.
12. Donkers B, Kazzaz B A, Meijering J H. Rhabdomyosarcoma of the corpus uteri: report of two cases with review of the literature. Am J Obstet Gynecol. 114:1972;1025-1030.
13. Siegal G P, Taylor L L, Nelson K G, Reddick R L, Frazelle M, Siegfried J M, Walton L A, Kaufman D G. Characterization of a pure heterologous sarcoma of the uterus: Rhabdomyosarcoma of the corpus. Int J Gynecol Pathol. 2:1983;303-315.
14. Jaworski R C, Rencoret R H, Moir D H. Pleomorphic rhabdomyosarcoma of the uterus: case report with a review of the literature. Br J Obstet Gynaecol. 91:1984;1269-1273.
15. Montag T W, D'ablaing G, Schlaerth J B, Gaddis O Jr., Morrow C P. Embryonal rhabdomyosarcoma of the uterine corpus and cervix. Gynecol Oncol. 25:1986;171-194.
16. Teshima H, Narahara H, Nishida J, Takada S, Cheng S Z, Mizutani K, Mori H, Kigawa T. Pure rhabdomyosarcoma of the corpus uteri: A case report with a review of the literature (abstract). Asia-Oceania J Obstet Gynaecol. 14:1988;301-305.
17. Podczaski E, Sees J, Kaminski P, Sorosky J, Larson J E, DeGeest K, Zaino R J, Mortel R. Rhabdomyosarcoma of the uterus in a postmenopausal patient. Gynecol Oncol. 37:1990;439-442.
18. Emerich J, Senkus E, Konefka T. Alveolar rhabdomyosarcoma of the uterine cervix. Gynecol Oncol. 63:1996;398-403.
19. Altaras M M, Aviram R, Cohen I, Cordoba M, Yarconi S, Beyth Y. Role of prolonged stimulation of tamoxifen therapy in the etiology of endometrial sarcomas. Gynecol Oncol. 49:1993;225-258.